Audrey Greenberg, co-founder and executive managing director of the Center for Breakthrough Medicines and Discovery Labs, discusses how cell and gene therapy has turned Philadelphia into Cellicon Valley, and how her organization is playing a role in that growth even beyond the city’s boarders.

Episode 89: Cellicon Valley Outlook

Tim Kress-Spatz, president at DoseID Consortium, an industry group established to unify an approach to serialized, radio-frequency identification (RFID) pharmaceutical products, and co-founder of Kit Check, which helps provide visibility into medication supply management, discusses RFID’s promise in downstream supply-chain tracking, the importance of interoperability in tracing drugs, reducing the inventory management burden for hospitals, and more.

Vision and Visibility: RFID’s Emergence in Healthcare

Pharmaceutical Commerce Magazine

Related tracks